Key facts
- This page summarizes Mads Bodenhoff's Form 4 filing for Ascendis Pharma A/S (ASND).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Sep 2026, 17:04.
Mads Bodenhoff - 08 Sep 2026 Form 4 Insider Report for Ascendis Pharma A/S (ASND)
- Reporting relationship
- SVP & PAO
- Issuer ticker
- ASND
- Reported as of
- 08 Sep 2026
- Net transaction value
- -$810,570
- SEC form
- 4
- Accepted by SEC
- 09 Sep 2026, 17:04:07 UTC
- Prior SEC filing
- 18 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Wolff Jensen as attorney-in-fact for Mads Bodenhoff
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mads Bodenhoff filed Form 4 for Ascendis Pharma A/S (ASND) on 09 Sep 2026.
Change
- Previous filing in this sequence was filed on 18 Mar 2026.
- Current net transaction value: -$810,570.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002014697
Primary reporting owner
Bodenhoff Mads
- Relationship
- SVP & PAO
- Address
- C/O ASCENDIS PHARMA A/S, TUBORG BOULEVARD 12, HELLERUP, DENMARK
- Signature
- /s/ Michael Wolff Jensen as attorney-in-fact for Mads Bodenhoff
- Signature date
- 10 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ASND
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +3,000
- Change %
- Price
- $110.00*
- Shares after
- 3,000
- Date
- 08 Sep 2026
- Ownership
- Direct
ASND
transaction
Ordinary Shares
Sale
- Transaction value
- $810,570
- Shares
- -3,000
- Change %
- -100%
- Price
- $270.19
- Shares after
- 0
- Date
- 08 Sep 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ASND
transaction
Derivative
Warrants
Options Exercise
- Transaction value
- Shares
- -3,000
- Change %
- -81%
- Price
- $0.000000*
- Shares after
- 687
- Date
- 08 Sep 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 3,000
- Exercise price
- $110.00
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The warrants vested 25% on October 11, 2023 and thereafter in 36 equal monthly installments.